REG - Indivior PLC - Director/PDMR Shareholding

IndiviorAnnouncement

03/03/2020 14:35

RNS Number : 8872E
  
Indivior PLC
  
03 March 2020
  
 

INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM
The Company announces that it received notification on March 2, 2020 that Graham Hetherington, a Non-Executive Director of the Company, acquired 30,000 shares at a price of £0.4446 per share.
Following this transaction, Graham Hetherington has an interest in 50,000 shares in the Company.
 



1


Details of the person discharging managerial responsibilities / person closely associated


 




a)
 


Name
 
 


Graham Hetherington


 




2
 


Reason for the notification
 


 




a)
 


Position/status
 
 


Non-Executive Director


 




b)
 


Initial notification /Amendment
 
 


Initial notification


 




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 


 




a)
 


Name
 
 


Indivior PLC


 




b)
 


LEI
 
 


213800V3NCQTY7IED471


 




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
  


 




a)
 


Description of the financial instrument, type of instrument
 
Identification code
  


Ordinary Shares of US$0.10
 
 
 
ISIN:  GB00BRS65X63


 




b)
 


Nature of the transaction
  


Purchase of shares
 


 




c)
 


Price(s) and volume(s)
 
 


 



Price(s)


Volume(s)




GBP 0.4446


30,000



  


 




d)
 


Aggregated information
 
- Aggregated volume
 
 
- Price
 


 
N/A
 
 
 
 


 




e)
 


Date of the transaction
  


March 2, 2020


 




f)
 


Place of the transaction
 


London Stock Exchange (XLON)


 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHUPUUWWUPUGCW